BioCell Therapies, Inc.
A leader in regenerative medicine, developing and manufacturing innovative healthcare technologies and products.
- Stage Concept Only
- Industry Biotechnology
- Location Minneapolis, MN, USA
- Currency USD
Company Summary
BioCell Therapies has developed a process and kits to isolate regenerative stem cells from a patient's own adipose tissue. Stem cell breast augmentation is considered to be the least invasive option there is, incorporating the transference of a woman's stored fat cells into the breast by means of injection. The BioCell Program educates technicians and others in the medical field, about stem cells and their use as therapeutics in medicine.
Team
-
Scott R. BromleyFounder and CEO
Scott R. Bromley also co-founded Bioheart, Inc. in 1999 and took it public in 2009. In 1986, he co-founded World Medical Corp. which merged with AVE in 1998 & was acquired by Medtronic, Inc. in early 1999. Mr. Bromley has over 25 years experience in the healthcare & medical device industry, involving the development of medical products, creation of marketing plans, quantification of markets and collateral materials.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.